Compare CNC & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNC | RMD |
|---|---|---|
| Founded | 1984 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1B | 34.0B |
| IPO Year | 2001 | 1996 |
| Metric | CNC | RMD |
|---|---|---|
| Price | $68.88 | $235.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 20 |
| Target Price | $71.78 | ★ $250.22 |
| AVG Volume (30 Days) | ★ 3.0M | 1.0M |
| Earning Date | 10-27-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | N/A | ★ 9.67 |
| EPS | 5.30 | ★ 10.43 |
| Revenue | ★ $194,777,000,000.00 | $2,957,013,000.00 |
| Revenue This Year | $11.22 | $2.67 |
| Revenue Next Year | N/A | $6.32 |
| P/E Ratio | ★ $12.67 | $22.52 |
| Revenue Growth | ★ 19.44 | 13.44 |
| 52 Week Low | $31.63 | $180.27 |
| 52 Week High | $69.63 | $277.67 |
| Indicator | CNC | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 66.24 | 65.20 |
| Support Level | $62.98 | $217.41 |
| Resistance Level | N/A | $242.40 |
| Average True Range (ATR) | 1.90 | 4.50 |
| MACD | 0.67 | 1.41 |
| Stochastic Oscillator | 97.12 | 88.16 |
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.